Riyadh — SFDA, the Saudi Food and Drug Authority, has approved the Moderna COVID-19 Vaccine for children aged 6-11 years.
This new legislation, passed on April 6, will increase vaccination coverage. The new vaccination program is expected to yield higher protection among wider age groups against the COVID-19 pandemic.
This approval comes as the Kingdom significantly recovers from the pandemic’s global economic effects.
Recommended: How to register for the COVID-19 Vaccine in Tawakalna App
And re-integrate its younger population into public life while ensuring their utmost safety and security. The new target population will translate to safer school environments and reduced transmissions.
Moderna was first approved in Saudi Arabia in July 2021 for persons above 18 years old. The SFDA initiative demonstrates immense confidence in Moderna’s high safety profile.
The ultimate focus is to decrease COVID-19-related hospitalizations.
